NASDAQ$DH

Definitive Healthcare Corp · Q2 2025 earnings

Q2 2025 earnings · · After market close · Investor relations

Briefing

Definitive Healthcare Corp reported revenue of $60.8 million and a net loss of $9.3 million for the second quarter of 2025.

The company saw revenue decline 5% year-over-year amid customer retention challenges and macroeconomic pressures. Net loss narrowed significantly to $9.3 million from $306.2 million in the prior year, with no goodwill impairment recorded this quarter. Cash and cash equivalents stood at $81.0 million at period end.

  • Revenue fell 5% to $60.8 million compared to Q2 2024
  • Net loss improved to $9.3 million from $306.2 million year-over-year
  • Loss from operations was $4.2 million versus $369.6 million in the prior year
  • Cash and cash equivalents totaled $81.0 million as of June 30, 2025

Headline financials

Total Revenue

$60.8M

Previous: $63.7M-4.7%
EPS (adj)

-$0.07

Previous: -$1.81+96.1%
Capital Expenditures

-$10M

Previous: -$676K-1379.1%
Net Income

-$7.55M

Previous: -$214M+96.5%
Operating Income

-$4.17M

Previous: -$370M+98.9%
Gross Profit

$46.6M

Previous: $50.5M-7.6%
Cash & Equivalents

$81M

Previous: $121M-33.0%

Revenue & EPS history

Definitive Healthcare · Revenue · Quarterly

$60.8M

Q2 2025-4.7%vs Q2 2024
Beat estimate in 13 of 15 quarters(87%)
ActualEstimate

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 18 quarterly earnings reports

Historical avg

-3.2%

Avg return

Earnings day

-5.7%

Avg return

5 days after

-5.8%

Avg return

30 days after

39%

7 / 18 earnings

Positive

+31.7%

Q1 2025

Best reaction

-34.3%

Q4 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q2 2025
Q1 2026-2.2%-2.0%-5.2%
Q4 2025-8.6%-12.9%-25.0%
Q3 2025+11.9%+2.6%-6.4%
Q1 2025+31.7%+21.4%+33.1%
Q4 2024-34.3%-43.7%-40.2%
Q3 2024-1.4%+6.3%+8.4%
Q2 2024-1.4%+5.1%+21.6%
Q1 2024-27.1%-27.5%-22.9%
Q4 2023+2.3%-4.2%-13.3%
Q3 2023+27.5%+29.5%+49.5%
Q2 2023-4.0%-6.2%-21.2%
Q1 2023+0.9%-3.7%+7.9%
Q4 2022+3.5%-1.6%-11.5%
Q3 2022-25.0%-29.7%-14.5%
Q2 2022-16.3%-18.6%-35.7%
Q1 2022-17.5%-31.3%-19.4%
Q4 2021+7.6%+13.6%+14.0%
Q3 2021-5.8%+0.2%-23.3%
Q2 2021
Q1 2021
Q4 2020
Q3 2020
Q2 2020
Q1 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro